Treating imatinib resistance in the few in CML-A key step towards cure in all

Francis J. Giles

doi:10.1016/j.leukres.2010.03.037

Treating imatinib resistance in the few in CML-A key step towards cure in all

Francis J. Giles

University of Texas Health Science Center San Antonio

Research output: Contribution to a Journal (Peer & Non Peer) › Editorial

1 Citation (Scopus)

Original language	English
Pages (from-to)	1123-1124
Number of pages	2
Journal	Leukemia Research
Volume	34
Issue number	9
DOIs	https://doi.org/10.1016/j.leukres.2010.03.037
Publication status	Published - Sep 2010
Externally published	Yes

Keywords

COX-2
HDAC
Imatinib
Nilotinib
Resistance

Access to Document

10.1016/j.leukres.2010.03.037

Cite this

@article{2a9862cef7e34341977e6fc68ae3c380,

title = "Treating imatinib resistance in the few in CML-A key step towards cure in all",

keywords = "COX-2, HDAC, Imatinib, Nilotinib, Resistance",

author = "Giles, \{Francis J.\}",

year = "2010",

month = sep,

doi = "10.1016/j.leukres.2010.03.037",

language = "English",

volume = "34",

pages = "1123--1124",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Treating imatinib resistance in the few in CML-A key step towards cure in all

AU - Giles, Francis J.

PY - 2010/9

Y1 - 2010/9

KW - COX-2

KW - HDAC

KW - Imatinib

KW - Nilotinib

KW - Resistance

UR - https://www.scopus.com/pages/publications/77955271198

U2 - 10.1016/j.leukres.2010.03.037

DO - 10.1016/j.leukres.2010.03.037

M3 - Editorial

SN - 0145-2126

VL - 34

SP - 1123

EP - 1124

JO - Leukemia Research

JF - Leukemia Research

IS - 9

ER -

Treating imatinib resistance in the few in CML-A key step towards cure in all

Keywords

Access to Document

Other files and links

Cite this